![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Wissing Michel D van Diest Paul J van der Wall Elsken Gelderblom Hans
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.22, Iss.5, 2013-06, pp. : 635-661
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Schelman William Liu Glenn Wilding George Morris Thomas Phung De Dreicer Robert
Investigational New Drugs, Vol. 29, Iss. 1, 2011-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Abiraterone acetate
By Ryan Charles J Cheng Michael L
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 1, 2013-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)